Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Regulatory News & FDA Approvals » EliTech SARS-CoV-2, Influenza, RSV Multiplex Test Receives CE Mark

EliTech SARS-CoV-2, Influenza, RSV Multiplex Test Receives CE Mark

Dec 15, 2020
|
staff reporter

NEW YORK – EliTech Group announced Tuesday its SARS-CoV-2 Plus Elite MGB Kit received CE marking and has been launched.

The kit detects and distinguishes between SARS-CoV-2, influenza A/B, and respiratory syncytial virus types A and B, the company said in a statement. It runs on the firm's Elite InGenius platform, as well as other major PCR thermocyclers. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Breathe It Out

Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.

The Next Batch

NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.

Switch for the Second

Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.

Science Reviews How Non-Genetic DNA Features Expand Utility of Liquid Biopsies, Presents Study of Enzymes in DNA Methylation

In Science this week: review discusses advances in liquid biopsies, and more.

What's Popular?

In Regulatory News & FDA Approvals

  1. CLIA Waiver in Hand, Binx Health Targeting Retailers, Urgent Care Centers With STI Tests

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.